Efferocytosis activates a DNMT3A-mediated oxidized DNA repair pathway to enable tissue resolution
Journal of Clinical Investigation · 2026
DOI: 10.1172/jci203265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Kleopatra Avrampou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA. Hauptthemen laut MEDLINE: Efferocytosis, DNA (Cytosine-5-)-Methyltransferases, Macrophages, DNA Repair. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NCI NIH HHS, NIH-NHLBI.
Abstract (Originalsprache)
Efferocytosis, the clearance of apoptotic cells by macrophages, promotes tissue resolution. Efficient resolution requires efferocytosis-induced macrophage proliferation (EIMP) to expand pro-resolving macrophages. Here, we show that efferocytosis activates base excision repair (BER) to remove 8-OHdG from DNA, enabling EIMP. Mechanistically, efferocytosis promotes poly(ADP-ribose) polymerase 1 (PARP1) chromatin binding and PARylation to facilitate DNA repair complex assembly and increases nuclear MutT homolog 1 (MTH1) (gene NUDT1 ), which hydrolyzes 8-OHdG. Both processes require DNA-methyltransferase-3A (DNMT3A), which is activated during efferocytosis. Using a model in which dexamethasone-induced thymocyte apoptosis triggers efferocytosis-mediated thymic repair, we showed that DNMT3A was required for increases in nuclear PARP1/MTH1, oxidized DNA suppression, EIMP in thymic macrophages, and thymic repair. We next studied a human-relevant model of atherosclerosis regression, whereby efferocytosis drove protective lesional fibrous cap thickening. We compared WT mice with a model of DNMT3A clonal hematopoiesis (CH), in which loss-of-function DNMT3A mutations promoted atherosclerotic disease. Atherosclerosis regression in WT mice led to decreased nuclear 8-OHdG and increased nuclear PARP1/MTH1 and EIMP in lesional macrophages and fibrous cap thickening, all of which were impaired in DNMT3A-CH regression. These findings reveal that efferocytosis initiates a BER pathway to allow macrophage proliferation for tissue resolution, with possible therapeutic relevance to atherosclerosis regression and DNMT3A-CH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.
- Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Department of Vascular and Endovascular Surgery, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
- Institute of Molecular Vascular Medicine, TUM Klinikum, Technical University of Munich, Munich, Germany.
- Department of Physiology and Cellular Biophysics and.
- Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.
Förderung
- NHLBI NIH HHS
- NCI NIH HHS
- NIH-NHLBI
Zitieren
APA
Avrampou, K., Sukka, S. R., Ngai, D., Ampomah, P. B., Wang, X., Kuriakose, G., Glass, J., Dorweiler, B., Winter, H., Maegdefessel, L., Zhang, H., Viny, A. D., & Tabas, I. (2026). Efferocytosis activates a DNMT3A-mediated oxidized DNA repair pathway to enable tissue resolution. Journal of Clinical Investigation. https://doi.org/10.1172/jci203265
Vancouver
Avrampou K, Sukka SR, Ngai D, Ampomah PB, Wang X, Kuriakose G, et al. Efferocytosis activates a DNMT3A-mediated oxidized DNA repair pathway to enable tissue resolution. Journal of Clinical Investigation. 2026. doi:10.1172/jci203265
BibTeX
@article{Avrampou2026,
author = {Avrampou, Kleopatra and Sukka, Santosh R and Ngai, David and Ampomah, Patrick B and Wang, Xiaobo and Kuriakose, George and Glass, Jacob and Dorweiler, Bernhard and Winter, Hanna and Maegdefessel, Lars and Zhang, Hanrui and Viny, Aaron D and Tabas, Ira},
title = {Efferocytosis activates a DNMT3A-mediated oxidized DNA repair pathway to enable tissue resolution},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci203265}
}
EUVIMED